Cargando…
Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876757/ https://www.ncbi.nlm.nih.gov/pubmed/24757238 http://dx.doi.org/10.2337/dc13-2781 |
| _version_ | 1782433285814616064 |
|---|---|
| author | Pierce, Gary L. Siefers, Kyle Wegman-Points, Lauren |
| author_facet | Pierce, Gary L. Siefers, Kyle Wegman-Points, Lauren |
| author_sort | Pierce, Gary L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4876757 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-48767572016-05-31 Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 Pierce, Gary L. Siefers, Kyle Wegman-Points, Lauren Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2014-05 2014-04-10 /pmc/articles/PMC4876757/ /pubmed/24757238 http://dx.doi.org/10.2337/dc13-2781 Text en © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Online Letters: Comments and Responses Pierce, Gary L. Siefers, Kyle Wegman-Points, Lauren Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 |
| title | Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 |
| title_full | Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 |
| title_fullStr | Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 |
| title_full_unstemmed | Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 |
| title_short | Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 |
| title_sort | comment on goldfine et al. targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (tinsal-fmd). diabetes care 2013;36:4132–4139 |
| topic | Online Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876757/ https://www.ncbi.nlm.nih.gov/pubmed/24757238 http://dx.doi.org/10.2337/dc13-2781 |
| work_keys_str_mv | AT piercegaryl commentongoldfineetaltargetinginflammationusingsalsalateinpatientswithtype2diabeteseffectsonflowmediateddilationtinsalfmddiabetescare20133641324139 AT sieferskyle commentongoldfineetaltargetinginflammationusingsalsalateinpatientswithtype2diabeteseffectsonflowmediateddilationtinsalfmddiabetescare20133641324139 AT wegmanpointslauren commentongoldfineetaltargetinginflammationusingsalsalateinpatientswithtype2diabeteseffectsonflowmediateddilationtinsalfmddiabetescare20133641324139 |